Loss of lamivudine resistance mutations after patients switched to adefovir dipivoxil therapy

被引：2
|
作者：
Westland, C [1 ]
Gibbs, C [1 ]
Miller, M [1 ]
Sullivan, M [1 ]
Fry, J [1 ]
Brosgart, C [1 ]
Wulfsohn, M [1 ]
Xiong, S [1 ]
机构：
[1] Gilead Sci Inc, Foster City, CA 94404 USA
来源：
JOURNAL OF HEPATOLOGY | 2002年 / 36卷
关键词：
D O I：
10.1016/S0168-8278(02)80015-0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
15
引用
收藏
页码：7 / 7
页数：1
相关论文
共 50 条
  • [21] Mutations Associated With the Therapeutic Efficacy of Adefovir Dipivoxil Added to Lamivudine in Patients Resistant to Lamivudine With Type B Chronic Hepatitis
    Ohkawa, Kazuyoshi
    Takehara, Tetsuo
    Kato, Michio
    Kanada, Aimi
    Deguchi, Matsuo
    Kagita, Masanori
    Hikita, Hayato
    Sasakawa, Akira
    Kohga, Keisuke
    Uemura, Akio
    Sakamori, Ryotaro
    Yamaguchi, Shinjiro
    Miyagi, Takuya
    Ishida, Hisashi
    Tatsumi, Tomohide
    Hayashi, Norio
    JOURNAL OF MEDICAL VIROLOGY, 2009, 81 (05) : 798 - 806
  • [22] EFFECTIVENESS OF LONG-TERM COMBINATION THERAPY WITH ADEFOVIR DIPIVOXIL AND LAMIVUDINE IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B AND LAMIVUDINE RESISTANCE
    Manolakopoulos, Spilios
    Striki, Athanasia
    Papatheodoridis, George V.
    Deutsch, Melanie
    Mela, Maria
    Tzourmakliotis, Dimitrios
    Manesis, Emanuel K.
    Archimandritis, Athanasios J.
    HEPATOLOGY, 2009, 50 (04) : 520A - 521A
  • [23] Two years efficiency of lamivudine and adefovir dipivoxil combined therapy in chronic hepatitis B patients
    Wang, H.
    Ji, Y. Y.
    Yao, G. B.
    Ma, X. Y.
    Xie, Q.
    Pang, H. Y.
    Wu, S. M.
    Li, J.
    Chen, C. W.
    Xu, X. W.
    Gu, E. L.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2013, 17 (05) : 636 - 643
  • [24] The comparison of adefovir dipivoxil or combination with lamivudine in patients with lamivudine resistant chronic hepatitis B
    Ayaz, Celal
    Celen, M. Kemal
    Geyik, M. Faruk
    Bayan, Kadim
    Dal, Tuba
    Altindis, Mustafa
    JOURNAL OF CLINICAL VIROLOGY, 2015, 70 : S118 - S119
  • [25] Long-term therapy with adefovir dipivoxil in hepatitis B e antigen-negative patients developing resistance to lamivudine
    Manalakopoulos, S.
    Bethanis, S.
    Koutsounas, S.
    Goulis, J.
    Vlachogiannakos, J.
    Christias, E.
    Savariadis, A.
    Pavlidis, C.
    Triantos, C.
    Christidou, A.
    Papatheodoridis, G.
    Karamanolis, D.
    Tzourmakliotis, D.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 27 (03) : 266 - 273
  • [26] Adefovir-dipivoxil/entecavir/lamivudine/telbivudineDrug resistance: 4 case reports
    Reactions Weekly, 2020, 1817 (1) : 19 - 19
  • [27] Clinical profile of HBeAg - Chronic hepatitis B patients with adefovir dipivoxil resistance mutations
    Lim, SG
    Hadziyannis, S
    Tassopoulos, N
    Chang, T
    Heathcote, J
    Kitis, G
    Rizzetto, M
    Marcellin, P
    Arterburn, S
    Qi, X
    Brosgart, CL
    Currie, G
    JOURNAL OF HEPATOLOGY, 2005, 42 : 184 - 184
  • [28] Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B
    Peters, MG
    Hann, HW
    Martin, P
    Heathcote, EJ
    Buggisch, P
    Rubin, R
    Bourliere, M
    Kowdley, K
    Trepo, C
    Gray, DF
    Sullivan, M
    Kleber, K
    Ebrahimi, R
    Xiong, S
    Brosgart, CL
    GASTROENTEROLOGY, 2004, 126 (01) : 91 - 101
  • [29] Early viral kinetics during therapy with lamivudine plus adefovir dipivoxil in patients with lamivudine resistant chronic hepatitis B.
    Mihm, U
    Gärtner, B
    Faust, D
    Sarrazin, C
    Zeuzem, S
    Herrmann, E
    HEPATOLOGY, 2004, 40 (04) : 669A - 669A
  • [30] Adefovir dipivoxil (ADV) for the treatment of patients with chronic hepatitis B (CHB) failing lamivudine (LAM) therapy
    Zoulim, F
    Trepo, C
    Poynard, T
    Pol, S
    Zarski, JP
    Marcellin, P
    Beaugrand, M
    Stitruk, V
    Trylesinski, A
    Kleber, K
    Van Doren, S
    Brosgart, C
    JOURNAL OF HEPATOLOGY, 2003, 38 : 184 - 184
12345